No abstract available
MeSH terms
-
Aftercare
-
Antineoplastic Agents, Hormonal / adverse effects
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Aromatase Inhibitors / therapeutic use
-
Breast Neoplasms, Male* / diagnosis
-
Breast Neoplasms, Male* / drug therapy
-
Breast Neoplasms, Male* / genetics
-
Breast Neoplasms, Male* / surgery
-
Chemotherapy, Adjuvant
-
Diagnosis, Differential
-
Genes, BRCA1
-
Genes, BRCA2
-
Humans
-
Male
-
Mutation
-
Prognosis
-
Risk Factors
-
Tamoxifen / adverse effects
-
Tamoxifen / therapeutic use
Substances
-
Antineoplastic Agents, Hormonal
-
Aromatase Inhibitors
-
Tamoxifen